Please login to the form below

Not currently logged in
Email:
Password:

Gocovri

This page shows the latest Gocovri news and features for those working in and with pharma, biotech and healthcare.

FDA approves new indication for Adamas’ Gocovri in Parkinson’s disease

FDA approves new indication for Adamas’ Gocovri in Parkinson’s disease

In two phase 3 clinical studies, Gocovri treatment was shown to significantly reduce both OFF time and dyskinesia. ... Gocovri is now the first and only medication approved to treat both OFF and dyskinesia motor complications in Parkinson’s disease,”

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Bedrock Healthcare Communications

Bedrock Healthcare Communications is an award-winning, independent agency founded in 2011. We partner with healthcare professionals, patients, and global pharmaceutical...

Latest intelligence

Virtual Steering Committee & Peer Influence Program
In this customer story, we describe the methodology and results of our client’s ongoing Virtual Steering Committee & Peer Influence program....
Meeting healthcare’s rising challenges
The journey to discover novel therapies through digital innovation and ensure scientific advances achieve their potential...
Report gives insights to address gaps in HCP engagement
How does Pharma-HCP engagement need to evolve in today's digital landscape?...